CTC (Chicago Trading Company)’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
CTC (Chicago Trading Company)'s NVAX Position: Q2 2022 in Review
CTC (Chicago Trading Company) sold out of Novavax (NVAX) in Q2 2022, closing a stake of 10,983 shares — an estimated $569K sold.
CTC (Chicago Trading Company) first reported a position in NVAX in Q3 2021 and held it in 3 quarters. The position peaked at $37.1M in Q3 2021. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- CTC (Chicago Trading Company) reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- CTC (Chicago Trading Company) sold 10,983 Novavax shares in Q2 2022, an estimated $569K.
- CTC (Chicago Trading Company) first reported a position in Novavax in Q3 2021 and held it in 3 quarters.
- CTC (Chicago Trading Company)'s Novavax position peaked at $37.1M in Q3 2021.
- 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on CTC (Chicago Trading Company)'s 13F filing for Q2 2022, filed 7 Jul 2022.